Human Papillomavirus–Associated Head and Neck Malignancies in Sub-Saharan Africa: A Systematic Review

PURPOSE The proportion of head and neck cancers (HNCs) with human papillomavirus (HPV) positivity in sub-Saharan Africa (SSA) is poorly characterized. Characterizing this has implications in staging, prognosis, resource allocation, and vaccination policies. This study aims to determine the proportion of HPV-associated HNC in SSA. MATERIALS AND METHODS This systematic review included searches from PubMed, EMBASE, Web of Science, African Index Medicus, Google Scholar, and African Journals Online. All English publications reporting the proportion of HNC specimens from SSA patients who tested positive for HPV and/or p16 were included. Study quality was assessed using the National Institutes of Health Quality Assessment Tool for Case Series Studies. RESULTS In this systematic review of 31 studies and 3,850 patients, the overall p16 positivity was 13.6% (41 of 1,037 patients tested) with the highest proportion among oropharyngeal cancers (20.3%, 78 of 384 patients) and the overall HPV polymerase chain reaction positivity was 15.3% (542 of 3,548 samples tested) with the highest proportion among nasopharyngeal cancers (16.5%, 23 of 139 patients). Among the 369 HPV strains detected, the most common genotypes were HPV 16 (226 patients, 59.2%) and HPV 18 (78, 20.4%). CONCLUSION HPV was found to be associated with a significant proportion of HNC in SSA. The genotypes reported suggest that the nine-valent vaccine and gender-neutral vaccination policies should be considered. Given that these studies may not accurately capture prevalence nor causation of HPV in HNC subsites, additional research is needed to provide a more thorough epidemiologic understanding of HPV-associated HNC in SSA, including risk factors and clinical outcomes.

[1]  C. Buchwald,et al.  A Contemporary Systematic Review on Repartition of HPV-Positivity in Oropharyngeal Cancer Worldwide , 2021, Viruses.

[2]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2021, BMJ.

[3]  Ayman Ahmed,et al.  Molecular detection of human papillomavirus-16 among Sudanese patients diagnosed with squamous cell carcinoma and salivary gland carcinoma , 2021, BMC research notes.

[4]  A. Ladeinde,et al.  Characterization of high risk human papilloma virus genotypes associated with oropharyngeal cancers in a Nigerian population , 2021, The Pan African medical journal.

[5]  C. Badoual,et al.  HPV Detection in Head and Neck Squamous Cell Carcinomas: What Is the Issue? , 2020, Frontiers in Oncology.

[6]  S. Kalungi,et al.  A descriptive study of human papilloma virus in upper aero-digestive squamous cell carcinoma at Uganda cancer institute assessed by P16 immunohistochemistry , 2020, Cancers of the Head & Neck.

[7]  R. Carlson,et al.  NCCN resource‐stratified and harmonized guidelines: A paradigm for optimizing global cancer care , 2020, Cancer.

[8]  W. Koch,et al.  African Head and Neck Society Clinical Practice guidelines for thyroid nodules and cancer in developing countries and limited resource settings , 2020, Head & neck.

[9]  S. Ratnam,et al.  Performance of AmpFire HPV assay on Neck Cervical Lymph Node Aspirate and Oropharyngeal Samples. , 2020, Journal of virological methods.

[10]  D. Goedhals,et al.  Human papillomavirus DNA in head and neck squamous cell carcinomas in the Free State, South Africa , 2020, Journal of medical virology.

[11]  L. Morris,et al.  Human papillomavirus and survival of patients with sinonasal squamous cell carcinoma , 2019, Cancer.

[12]  H. Péré,et al.  Infrequent detection of human papillomavirus infection in head and neck cancers in the Central African Republic: a retrospective study , 2019, Infectious Agents and Cancer.

[13]  C. Obirikorang,et al.  Human Papillomavirus Detection in Head and Neck Squamous Cell Carcinomas at a Tertiary Hospital in Sub-Saharan Africa , 2019, TheScientificWorldJournal.

[14]  D. Goedhals,et al.  Human papillomavirus in head and neck squamous cell carcinomas in a South African cohort , 2018, Papillomavirus research.

[15]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[16]  W. Yarbrough,et al.  Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival , 2018, JAMA otolaryngology-- head & neck surgery.

[17]  G. Nunnari,et al.  Head and neck squamous cell carcinoma and its correlation with human papillomavirus in people living with HIV: a systematic review , 2018, Oncotarget.

[18]  W. Funkhouser,et al.  Human papillomavirus in head and neck squamous cell carcinoma: A descriptive study of histologically confirmed cases at Kamuzu Central Hospital in Lilongwe, Malawi , 2017, Malawi medical journal : the journal of Medical Association of Malawi.

[19]  A. Adjei,et al.  Detection of Human Papillomavirus Genotypes and Epstein-Barr Virus in Nasopharyngeal Carcinomas at the Korle-Bu Teaching Hospital, Ghana , 2017, TheScientificWorldJournal.

[20]  Brian O'Sullivan,et al.  Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.

[21]  F. Bray,et al.  The burden of HPV associated cancers in two regions in Nigeria 2012-2014. , 2016, Cancer epidemiology.

[22]  M. Poljak,et al.  HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients. , 2016, Journal of the National Cancer Institute.

[23]  C. Adebamowo,et al.  Paucity of HPV-Related Head and Neck Cancers (HNC) in Nigeria , 2016, PloS one.

[24]  M. Prasad,et al.  Investigation of the presence of HPV related oropharyngeal and oral tongue squamous cell carcinoma in Mozambique. , 2015, Cancer epidemiology.

[25]  C. Shores,et al.  Review: Head and neck squamous cell carcinoma in sub-Saharan Africa. , 2015, Malawi medical journal : the journal of Medical Association of Malawi.

[26]  Richard D Moore,et al.  Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals. , 2014, Oral oncology.

[27]  F. Feng,et al.  Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis. , 2014, International journal of radiation oncology, biology, physics.

[28]  C. Lacey,et al.  The burden of human papillomavirus infections and related diseases in sub-saharan Africa. , 2013, Vaccine.

[29]  K. Cooper,et al.  Evidence That Alpha-9 Human Papillomavirus Infections are a Major Etiologic Factor for Oropharyngeal Carcinoma in Black South Africans , 2013, Head and Neck Pathology.

[30]  S. Sanjosé,et al.  The role of human papillomavirus in head and neck cancer in Senegal , 2013, Infectious Agents and Cancer.

[31]  I. Ginawi,et al.  Immunophenotyping of HPV Types 16 and 18 among Sudanese Patients with Oral Lesions. , 2012, Oman medical journal.

[32]  A. Dempsey,et al.  The role of HPV in head and neck cancer and review of the HPV vaccine. , 2011, Preventive medicine.

[33]  J. Hirsch,et al.  Presence of human papilloma virus, herpes simplex virus and Epstein-Barr virus DNA in oral biopsies from Sudanese patients with regard to toombak use. , 2010, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[34]  W. V. van Heerden,et al.  HPV detection in primary intra-oral squamous cell carcinomas--commensal, aetiological agent or contamination? , 2006, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.